Yu Dao-Yi, Cringle Stephen J
Centre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, Perth, WA 6009, Australia.
Exp Eye Res. 2005 Jun;80(6):745-51. doi: 10.1016/j.exer.2005.01.018.
Vision loss due to various forms of outer retinal degeneration remains a major problem in clinical ophthalmology. Most retinal degenerations are precipitated by genetic mutations affecting the retinal pigment epithelium and sensory retina, but it is becoming increasingly evident that resultant metabolic changes within the retina may also contribute to the further progression of photoreceptor cell loss. In particular, a role for the local oxygen environment within the retina has been proposed. The correct balance between retinal oxygen supply and oxygen consumption in the retina is essential for retinal homeostasis, and disruption of this balance is a factor in many retinal diseases. In animal models of photoreceptor degeneration, manipulation of environmental oxygen levels has been reported to be able to modulate the rate of photoreceptor degeneration. Clinically, hyperbaric oxygen therapy has already been used in retinitis pigmentosa patients and other types of oxygen therapy have been proposed. It therefore seems appropriate to review our current understanding of the oxygen environment in the normal and degenerating retina, and to build a clearer picture of how the retinal oxygen environment can be modulated. We focus on techniques that have been, or may be, applied clinically, such as modulation of systemic oxygen levels and modulation of retinal oxygen metabolism by light deprivation. Data from direct measurements of intraretinal oxygen distribution in rat models at different stages of photoreceptor degeneration will be reviewed. These models include the Royal College of Surgeons (RCS) rat, and the P23H rat model of outer retinal degeneration. Microelectrode based techniques have allowed the intraretinal oxygen distribution to be measured as a function of retinal depth under well-controlled systemic conditions at different stages of the degeneration process. Both models showed changes in the intraretinal oxygen distribution during the degenerative period, with the changes reflecting the gradual loss of oxygen metabolism of the degenerating photoreceptors. This results in higher than normal oxygen levels in the remaining outer retina and a significant alteration in the oxygen flux from the choroid to the inner retina. The maintenance of normal oxygen levels in the inner retina implies that inner retinal oxygen uptake is well preserved, and that there is also reduced oxygen input from the deeper capillary layer of the retinal circulation. Choroidal oxygen tension and the oxygen tension in the pre-retinal vitreous were unaffected at any of the time periods studied prior to, and during, the degeneration process. It is well known that both hypoxia and hyperoxia can cause neural cell stress and damage. Logically, any therapeutic intervention based on oxygen therapy should attempt to restore the oxygen environment of the remaining retinal cells to within the physiological range. Before any oxygen based therapies for the treatment of retinal degeneration should be seriously considered, the oxygen environment in the degenerating retina should be determined, along with clinically usable methods to restore the oxygen environment to the critical cell layers.
由于各种形式的外层视网膜变性导致的视力丧失仍是临床眼科中的一个主要问题。大多数视网膜变性是由影响视网膜色素上皮和感觉视网膜的基因突变引发的,但越来越明显的是,视网膜内由此产生的代谢变化也可能导致光感受器细胞损失的进一步发展。特别是,视网膜内局部氧环境的作用已被提出。视网膜中氧供应与氧消耗之间的正确平衡对于视网膜稳态至关重要,而这种平衡的破坏是许多视网膜疾病的一个因素。在光感受器变性的动物模型中,据报道操纵环境氧水平能够调节光感受器变性的速率。临床上,高压氧疗法已用于色素性视网膜炎患者,并且已经提出了其他类型的氧疗法。因此,回顾我们目前对正常和变性视网膜中氧环境的理解,并更清楚地了解如何调节视网膜氧环境似乎是合适的。我们关注已经或可能在临床上应用的技术,例如调节全身氧水平和通过剥夺光来调节视网膜氧代谢。将回顾来自在光感受器变性不同阶段的大鼠模型中视网膜内氧分布的直接测量数据。这些模型包括皇家外科医学院(RCS)大鼠和外层视网膜变性的P23H大鼠模型。基于微电极的技术允许在变性过程的不同阶段,在良好控制的全身条件下,将视网膜内氧分布测量为视网膜深度的函数。两个模型在变性期间均显示视网膜内氧分布的变化,这些变化反映了变性光感受器氧代谢的逐渐丧失。这导致剩余外层视网膜中的氧水平高于正常水平,并且从脉络膜到内层视网膜的氧通量发生显著改变。内层视网膜中正常氧水平的维持意味着内层视网膜的氧摄取得到很好的保留,并且来自视网膜循环较深毛细血管层的氧输入也减少。在变性过程之前和期间研究的任何时间段内,脉络膜氧张力和视网膜前玻璃体中的氧张力均未受影响。众所周知,缺氧和高氧均可导致神经细胞应激和损伤。从逻辑上讲,任何基于氧疗法的治疗干预都应尝试将剩余视网膜细胞的氧环境恢复到生理范围内。在认真考虑任何用于治疗视网膜变性的氧疗法之前,应确定变性视网膜中的氧环境以及将氧环境恢复到关键细胞层的临床可用方法。